Journal
EUROPEAN JOURNAL OF HAEMATOLOGY
Volume 94, Issue 6, Pages 511-518Publisher
WILEY
DOI: 10.1111/ejh.12464
Keywords
thalassemia; hepcidin; erythropoiesis; iron metabolism; GDF15; ferritin; soluble transferrin receptor; erythropoietin
Categories
Funding
- CNPq of Brazil [141608/2011-0]
- CAPES of Brazil [18584-12-8]
- NIH of Weill Cornell of Medical College of USA [1R01DK090554, 5R01DK095112]
Ask authors/readers for more resources
The thalassemia syndromes (- and -thalassemia) are the most common and frequent disorders associated with ineffective erythropoiesis. Imbalance of - or -globin chain production results in impaired red blood cell synthesis, anemia, and more erythroid progenitors in the blood stream. While patients affected by these disorders show definitive altered parameters related to erythropoiesis, the relationship between the degree of anemia, altered erythropoiesis, and dysfunctional iron metabolism has not been investigated in both -thalassemia carriers (ATC) and -thalassemia carriers (BTC). Here, we demonstrate that ATC have a significantly reduced hepcidin and increased soluble transferrin receptor levels but relatively normal hematological findings. In contrast, BTC have several hematological parameters significantly different from controls, including increased soluble transferrin receptor and erythropoietin levels. These changes in both groups suggest an altered balance between erythropoiesis and iron metabolism. The index sTfR/log ferritin and (hepcidin/ferritin)/sTfR are, respectively, increased and reduced relative to controls, proportional to the severity of each thalassemia group. In conclusion, we showed in this study, for the first time in the literature, that thalassemia carriers have altered iron metabolism and erythropoiesis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available